Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients
Clinical trial NCT00577993 · COMPLETED
Trial details
- NCT number
- NCT00577993
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-03-16
- Primary completion
- 2017-08-24
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.